Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Radha Rajasingham and David Boulware.
Radha Rajasingham
Connection Strength
3.290
David Boulware
  1. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017 08; 17(8):873-881.
    View in: PubMed
    Score: 0.715
  2. Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial. Clin Infect Dis. 2021 06 01; 72(11):e835-e843.
    View in: PubMed
    Score: 0.237
  3. Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global Pandemic. Open Forum Infect Dis. 2021 Feb; 8(2):ofaa602.
    View in: PubMed
    Score: 0.230
  4. Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19. Open Forum Infect Dis. 2020 Nov; 7(11):ofaa500.
    View in: PubMed
    Score: 0.227
  5. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial. Ann Intern Med. 2020 10 20; 173(8):623-631.
    View in: PubMed
    Score: 0.223
  6. Symptoms of COVID-19 Outpatients in the United States. Open Forum Infect Dis. 2020 Jul; 7(7):ofaa271.
    View in: PubMed
    Score: 0.222
  7. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020 08 06; 383(6):517-525.
    View in: PubMed
    Score: 0.221
  8. Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial. Can J Anaesth. 2020 09; 67(9):1201-1211.
    View in: PubMed
    Score: 0.220
  9. Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19). Open Forum Infect Dis. 2020 Apr; 7(4):ofaa130.
    View in: PubMed
    Score: 0.219
  10. A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in Uganda. Medicine (Baltimore). 2018 Aug; 97(31):e11722.
    View in: PubMed
    Score: 0.195
  11. A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in Uganda. J Acquir Immune Defic Syndr. 2018 06 01; 78(2):231-238.
    View in: PubMed
    Score: 0.193
  12. Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)-Positive Human Immunodeficiency Virus-Infected Persons in an Ethiopian CrAg Screening Program. Clin Infect Dis. 2017 Nov 29; 65(12):2126-2129.
    View in: PubMed
    Score: 0.186
  13. A Systematic Review of Treatment and Outcomes of Pregnant Women With COVID-19-A Call for Clinical Trials. Open Forum Infect Dis. 2020 Sep; 7(9):ofaa350.
    View in: PubMed
    Score: 0.056
  14. Finding the Dose for Hydroxychloroquine Prophylaxis for COVID-19: The Desperate Search for Effectiveness. Clin Pharmacol Ther. 2020 10; 108(4):766-769.
    View in: PubMed
    Score: 0.055
  15. Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts. BMC Neurol. 2017 Jun 12; 17(1):110.
    View in: PubMed
    Score: 0.045
  16. Differences in Immunologic Factors Among Patients Presenting with Altered Mental Status During Cryptococcal Meningitis. J Infect Dis. 2017 03 01; 215(5):693-697.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.